'Mutation status' presentation slideshows

Michael F Driscoll, MD Chief Fellow Medical Oncology / Hematology JGBCC University of Louisville

Update of 2010 American Society of Clinical Oncology (ASCO) Annual Meeting: Gastrointestinal Malignancies. Michael F Driscoll, MD Chief Fellow Medical Oncology / Hematology JGBCC University of Louisville. An Update on Gastrointestinal Cancer: Overview.

779 views • 58 slides

Cancer Statistics

Clinical Application of Next Generation Sequencing for Personalized Medicine in Solid Tumors Presented by: Ryan Bender, PhD FACMG. Cancer Statistics. Evolution of Knowledge in NSCLC. Traditionally, non-small-cell lung cancers have been classified according to histological features.

505 views • 30 slides

????? EGFR ?????????????

????? EGFR ?????????????. ? ? ?????????? ??????. IPASS Study:Progression-free survival by EGFR mutation type (ITT population). Exon 19 deletion. L858R. Gefitinib (n=66) Carboplatin/paclitaxel (n=74). Gefitinib (n=64) Carboplatin/paclitaxel (n=47). 1.0. 1.0.

730 views • 24 slides

COIN Trial design

Identification of potentially responsive subsets when cetuximab is added to oxaliplatin-fluoropyrimidine chemotherapy (CT) in first line advanced colorectal cancer (aCRC): mature results of the MRC COIN trial

369 views • 18 slides

310 views • 11 slides

???????????????? BRAF V600E ??

???????????????? BRAF V600E ??. ??????????? ?? 2014 ? 3 ? 26 ?. Homogeneity and heterogeneity. Detection comparison. Three technical problems. ????.

531 views • 9 slides

Gene expression profiles depend on tumor locations in

Gene expression profiles depend on tumor locations in Colorectal Cancer (left vs. right vs. rectum).

73 views • 1 slides

BACKGROUND

Correlation of ERCC1 mRNA expression with KRAS mutation status in colorectal, pancreatic, and lung adenocarcinoma.

102 views • 1 slides